Loading…
Peginterferon α-2a (40kD) [Pegasys®] improves HR-QOL outcomes compared with unmodified interferon α-2a [Roferon®-A]: In patients with chronic hepatitis C
Saved in:
Published in: | PharmacoEconomics 2003, Vol.21 (5), p.341-349 |
---|---|
Main Authors: | , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | |
---|---|
ISSN: | 1170-7690 1179-2027 |
DOI: | 10.2165/00019053-200321050-00005 |